Over the past decade, the biotechnology research and experimental development sector in Germany has seen a mix of up and down trends in wages and salaries. Starting with a value of 451.0 Million Euros in 2013, the sector experienced notable peaks, such as in 2018 with 970.4 Million Euros. Despite a slight dip in subsequent years, the marked recovery has been evident, reaching 970.6 Million Euros by 2023.
Key variations to note:
- 2014 saw a substantial year-on-year increase of 21.95% compared to 2013.
- The year 2018 had a year-on-year surge of 36.29%, indicating significant sectoral growth.
- Conversely, 2019 and 2020 experienced declines of 5.89% and 4.02% year-on-year, respectively, suggesting short-term volatility.
- Recently, 2022 and 2023 showed steady year-on-year rises of 3.43% and 3.26% respectively.
Looking forward, forecasted data from 2024 to 2028 reveal an expected growth of 11.5% with a CAGR of 2.2%. This indicates a positive outlook, driven by continuous investments and advancements in biotechnology.
Future trends to watch for in this sector include:
- Increased government and private funding aimed at accelerating biotechnological research.
- Innovations in pharmaceutical biotechnology that may drive further wage growth.
- The potential impact of regulatory changes within the European Union on R&D expenditure.
- Developments in automation and artificial intelligence in research that might influence workforce requirements.
